Names, Facts, Figures about Bayer
Bayer is a Life Science company with a more than 150-year history and core competencies in the areas of health care and agriculture. With our innovative products, we are contributing to finding solutions to some of the major challenges of our time.
A growing and aging world population requires an adequate supply of food and improved medical care. With our innovative products, we are contributing to finding solutions to some of the major challenges of our time. With life expectancy continuing to rise, we improve quality of life for a growing population by focusing our research and development activities on preventing, alleviating and treating diseases. We are also making an important contribution to providing a reliable supply of high-quality food, feed and plant-based raw materials.
Our goal is to create value for our customers, stockholders and employees, while also strengthening the company’s earning power. We are committed to operating sustainably and addressing our social and ethical responsibilities. Employees with a passion for innovation enjoy excellent development opportunities at Bayer. All this goes to make up our purpose:
Exclusive Focus on the Life Science Businesses
The Bayer Group is managed as a life science company with three divisions – Pharmaceuticals, Consumer Health and Crop Science. The Enabling Functions support the operational business. In 2022, the Bayer Group comprised 354 consolidated companies in 83 countries.
Structure of the Bayer Group
Organization chart with management structure and fields of activity (PDF, 384 KB)
Business Operations Are the Responsibility of the Divisions:
The Pharmaceuticals Division focuses on prescription products, especially for cardiology and women’s healthcare, and on specialty therapeutics in the areas of oncology, hematology and ophthalmology. The division also comprises the radiology business, which markets diagnostic imaging equipment together with the necessary contrast agents.
The Consumer Health division markets mainly nonprescription (OTC = over-the-counter) products in the dermatology, nutritional supplement, analgesic, digestive health, cold, allergy, sinus and flu categories.
The Crop Science Division is a world-leading agriculture enterprise with businesses in seeds, crop protection and nonagricultural pest control. The Crop Protection / Seeds operating unit markets a broad portfolio of high-value seeds and innovative pest management solutions, while at the same time providing extensive customer service for sustainable agriculture.
Central Service Functions:
The Enabling Functions operate as Group-wide competence centers in which business support services are bundled.
Corporate Governance
Dual governance system with the following governance bodies:
| Board of Management: | six members, Chairman: Bill Anderson |
| Supervisory Board: | 20 members, Chairman: Prof. Dr. Norbert Winkeljohann |
Locations
The Bayer Group comprises 354 consolidated companies** in 83 countries. Global headquarters are in Leverkusen, Germany.
- **fully consolidated subsidiaries (as of December. 31, 2022)
Our Employees
On December 31, 2022, Bayer employed 101,369 (2021: 99,637) people worldwide. In Germany we had 22,569 (2021: 23,116) employees, which was 22.3% of the total Bayer Group workforce (2021: 23.2%).
Employees by Region and Gender in 2022
Read more about working at Bayer
Jobs and Career
Bayer Stock
-
included in nearly all the major share indices
-
traded on all German stock exchanges
-
dividend per share proposed to €2.4 (2022)
Bayer Group Key Data |
|||
|---|---|---|---|
| Bayer Group | 2021 | 2022 | Change |
| € million | € million | % | |
| Sales | 44,081 | 50,739 | 15.10 |
| EBIT1 | 3,353 | 7,012 | 109.13 |
| EBIT before special items2 | 7,295 | 9,257 | 26.90 |
| EBITDA3 | 6,409 | 13,515 | 110.88 |
| EBITDA before special items2 | 11,179 | 13,513 | 20.88 |
| EBITDA margin before special items (in %)4 | 25.4 | 26.6 | 4.72 |
| Income before income taxes | 2,046 | 4,670 | 128.25 |
| Net income | 1,000 | 4,150 | 315.00 |
| Earnings per share (€)5 | 1.02 | 4.22 | 313.73 |
| Core earnings per share (€)6 | 6.51 | 7.94 | 21.97 |
| Net financial debt | 33,137 | 31,809 | -4.01 |
| Capital expenditures as per segment table | 3,004 | 3,639 | 21.14 |
| Research and development expenses | 5,412 | 6,572 | 21.43 |
| Dividend per Bayer AG share (€) | 2.00 | 2.4 | 20.00 |
|
figures restated |
|||